University Hospitals Birmingham NHS Foundation Trust

Reports

Status Drug name NICE TAs Comments
Status: Green GTN 0.4% ointment (Rectogesic)

First choice

Status: Red Guanfacine (Intuniv®)

2nd line Atomoxetine, hospitals to manage/support patient. For the treatment of ADHD in children and adolescents 6-17 years old for whom stimulants are not suitable, not tolerated or have been shown to be ineffective.

Status: Red Haem arginate (Normasang)

NHSE commissioned.

Status: Green Haemophilus Type B Minigococcal Group C Conjugate vaccine (Menitorix®)

Supported with PGD

Status: Amber Haloperidol capsules

ESCA

Status: Amber Haloperidol decanoate injection

Specialist initiation only

Status: Amber Haloperidol SF liquid

ESCA

Status: Green Healthy Start vitamins

Available free of charge from designated centres.

Status: Green Heliobacter stool antigen test

In line with NICE/PHE guidance. Check availability of test in local laboratory.

Status: Green Heliobacter urea breath test

In line with NICE/PHE guidance.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top